Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Protein Science

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/pro.3091PMID 27977889PMCID PMC5326557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• E2 enzymes: more than just middle men

  2016cited by this paper
• Human BRCA1–BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection

  2016cited by this paper
• Hemi-methylated DNA regulates DNA methylation inheritance through allosteric activation of H3 ubiquitylation by UHRF1

  2016cited by this paper
• Massively Parallel Functional Analysis of BRCA1 RING Domain Variants

  2015cited by this paper
• University of Dundee Structural basis for the RING catalyzed synthesis of K63 linked ubiquitin chains

  2015cited by this paper
• BMI1–RING1B is an autoinhibited RING E3 ubiquitin ligase

  2015cited by this paper
• Allosteric Activation of the RNF146 Ubiquitin Ligase by a Poly(ADP-ribosyl)ation Signal

  2014cited by this paper
• Crystal structure of the PRC1 ubiquitylation module bound to the nucleosome

  2014cited by this paper
• RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination.

  2014cited by this paper
• Activity-enhancing mutations in an E3 ubiquitin ligase identified by high-throughput mutagenesis

  2013cited by this paper
• Structure and E 3-ligase activity of the Ring – Ring complex of Polycomb proteins Bmi 1 and Ring 1 b

  2013cited by this paper
• The Ubiquitin-conjugating Enzyme (E2) Ube2w Ubiquitinates the N Terminus of Substrates*

  2013cited by this paper
• BIRC7–E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer

  2012cited by this paper
• Structure of an E3:E2~Ub complex reveals an allosteric mechanism shared among RING/U-box ligases.

  2012cited by this paper
• Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis

  2012cited by this paper
• Recognition of UbcH5c and the nucleosome by the Bmi1/Ring1b ubiquitin ligase complex

  2011cited by this paper
• BRCA1 Tumor Suppression Depends on BRCT Phosphoprotein Binding, But Not Its E3 Ligase Activity

  2011cited by this paper
• Symmetry and asymmetry of the RING-RING dimer of Rad18.

  2011cited by this paper
• BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.

  2011cited by this paper
• BRCA1 tumor suppression occurs via heterochromatin mediated silencing

  2011cited by this paper
• The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor.

  2011cited by this paper
• Role of a ribosome-associated E3 ubiquitin ligase in protein quality control

  2010cited by this paper
• BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.

  2010cited by this paper
• Molecular basis for the association of human E4B U box ubiquitin ligase with E2-conjugating enzymes UbcH5c and Ubc4.

  2010cited by this paper
• RING domain E3 ubiquitin ligases.

  2009cited by this paper
• Interactions between the quality control ubiquitin ligase CHIP and ubiquitin conjugating enzymes

  2008cited by this paper
• Structures of the cIAP2 RING Domain Reveal Conformational Changes Associated with Ubiquitin-conjugating Enzyme (E2) Recruitment*

  2008cited by this paper
• E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks

  2008cited by this paper
• E2–BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages

  2007cited by this paper
• Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.

  2007cited by this paper
• Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase

  2007cited by this paper
• BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.

  2006cited by this paper
• A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination.

  2006cited by this paper
• Structure and E3‐ligase activity of the Ring–Ring complex of Polycomb proteins Bmi1 and Ring1b

  2006cited by this paper
• Controlled synthesis of polyubiquitin chains.

  2005cited by this paper
• Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression*

  2004cited by this paper
• Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex

  2003cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001cited by this paper
• Structure of a BRCA1–BARD1 heterodimeric RING–RING complex

  2001cited by this paper
• Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases.

  2000cited by this paper
• Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair.

  1999cited by this paper
• Mapping the Functional Domains of BRCA1

  1999cited by this paper
• The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.

  1999cited by this paper
• RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination.

  1999cited by this paper
• The Cancer-predisposing Mutation C61G Disrupts Homodimer Formation in the NH2-terminal BRCA1 RING Finger Domain*

  1998cited by this paper
• Identification of a RING protein that can interact in vivo with the BRCA1 gene product

  1996cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• A novel gysteine-rich sequence motif

  1991cited by this paper
• Linkage of early-onset familial breast cancer to chromosome 17q21.

  1990cited by this paper
• Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown.

  1983cited by this paper

• Exploiting E3 ligases for lung cancer therapy: The promise of DCAF-PROTACs.

  2025cites this paper
• A New Class of BRCA1 Mimetics for ERα-Positive Breast Cancer Therapy: Design, Synthesis, In Silico Screening, In Vitro Assay, and Gene Expression Analysis

  2025cites this paper
• Pathogenic BRCA1 mutations disrupt allosteric control by BARD1

  2025cites this paper
• UBE2A and UBE2B are recruited by an atypical E3 ligase module in UBR4

  2024cites this paper
• Brca1 mouse models: functional insights and therapeutic opportunities.

  2023cites this paper
• Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair.

  2023cites this paper
• Zooming into the structure-function of RING finger proteins for anti-cancer therapeutic applications.

  2023cites this paper
• Identification of RNF150 as the hub gene associated with microsatellite instability in gastric cancer

  2023cites this paper
• In silico investigation on the mutational analysis of BRCA1-BARD1 RING domains and its effect on nucleosome recognition and ubiquitination.

  2023cites this paper
• An Atypical E3 Ligase Module in UBR4 Mediates Destabilization of N-degron Substrates

  2023cites this paper
• Molecular dynamics simulations reveal the effect of mutations in the RING domains of BRCA1-BARD1 complex and its relevance to the prognosis of breast cancer

  2023influential citation
• E2 Partner Tunes the Ubiquitylation Specificity of Arkadia E3 Ubiquitin Ligase

  2023cites this paper
• Differential requirement for BRCA1-BARD1 E3 ubiquitin ligase activity in DNA damage repair and meiosis in the Caenorhabditis elegans germ line

  2022cites this paper
• The BRCA1/BARD1 ubiquitin ligase and its substrates.

  2021cites this paper
• Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers

  2021cites this paper
• Control of Genome through Variative Nature of Histone-Modifying Ubiquitin Ligases

  2021cites this paper
• RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage

  2021cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication

  2020cites this paper
• Dual Modulators of p53 and Cyclin D in ER Alpha Signaling by Albumin Nanovectors Bearing Zinc Chaperones for ER Positive Breast Cancer Therapy.

  2020cites this paper
• Who with whom: functional coordination of E2 enzymes by RING E3 ligases during poly‐ubiquitylation

  2020cites this paper
• Structural basis for RING-Cys-Relay E3 Ligase Activity and its Role in Axon Integrity

  2020cites this paper
• Substrate-induced clustering activates Trim-Away of pathogens and proteins

  2020cites this paper
• Cracking the Monoubiquitin Code of Genetic Diseases

  2020influential citation
• Writing Histone Monoubiquitination in Human Malignancy—The Role of RING Finger E3 Ubiquitin Ligases

  2019influential citation
• Structural basis of homologous recombination

  2019cites this paper
• Designing active RNF4 monomers by introducing a tryptophan: avidity towards E2∼Ub conjugates dictates the activity of ubiquitin RING E3 ligases.

  2019cites this paper
• Correcting errors in the BRCA1 warning system.

  2019cites this paper
• The tumor suppressor BRCA1-BARD1 complex localizes to the synaptonemal complex and regulates recombination under meiotic dysfunction in Caenorhabditis elegans

  2018cites this paper
• USP48 restrains resection by site-specific cleavage of the BRCA1 ubiquitin mark from H2A

  2018cites this paper